Nautilus, Inc. (NLS) News
Filter NLS News Items
NLS News Results
|Loading, please wait...|
NLS News Highlights
- For NLS, its 30 day story count is now at 13.
- Over the past 21 days, the trend for NLS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about NLS are WASH, BEAT and CVS.
Latest NLS News From Around the Web
Below are the latest news stories about Nautilus Inc that investors may wish to consider to help them evaluate NLS as an investment opportunity.
SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating virtually in the upcoming 42 nd Annual Cowen Health Care Conference.
No summary available.
One thing we could say about the analysts on Nautilus, Inc. ( NYSE:NLS ) - they aren't optimistic, having just made a...
Nautilus, Inc. (NLS) Q3 2022 Earnings Conference Call February 9, 2022, 4:30 PM ET Company Participants Jim Barr – Chief Executive Officer Aina Konold – Chief Financial Officer John Mills – Investor Relations Contact Officer Conference Call Participants Michael Swartz – Truist Securities Sharon Zackfia – William Blair Steve Dyer...
NLS earnings call for the period ending December 31, 2021.
EQUINOX President Scott DeRue joins Yahoo Finance Live to discuss the global gym brand's attendance in the late-pandemic, models to design unique fitness experiences, fitness market trends, and inflation.
VANCOUVER, Wash., February 09, 2022--Nautilus, Inc. (NYSE: NLS) today reported its unaudited operating results for the fiscal 2022 third quarter and for the nine-months ended December 31, 2021.
Nautilus (NYSE:NLS) is scheduled to announce Q3 earnings results on Wednesday, February 9th, after market close.The consensus EPS Estimate is -$0.49 and the consensus Revenue Estimate…
Investment company North Growth Management Ltd. (Current Portfolio) buys PerkinElmer Inc, Global Payments Inc, Syneos Health Inc, Tapestry Inc, Abercrombie & Fitch Co, sells Gilead Sciences Inc, Itron Inc, American Eagle Outfitters Inc, Cerner Corp, Boston Scientific Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, North Growth Management Ltd..
Nautilus (NLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.